|

PRV131 (Cisplatin Intratumoral Injectable) Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 2/3: 1

Top Sponsors

  • Privo Technologies1

Indications

  • Oral Squamous Cell Carcinoma1
  • Lung Cancer1
  • Cancer1

Duarte, California1 trial

A Study Evaluating the Safety and Efficacy of PRV111, PRV211, and PRV131 in Subjects With Oral and Lung Cancers

City of Hope National Medical Center

Phase 2/3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.